GENETICS OF NK CELL RECEPTORS AND HLA LIGANDS

$256,840P01FY2009CANIH

Sloan-Kettering Inst Can Research, New York NY

Investigators

Linked publications, trials & patents

Paper 39293438 Paper 39112630 Paper 38838781 Paper 38728378 Paper 38579288 Paper 38496653 Paper 38429422 Paper 38383769 Paper 38343800 Paper 38332462 Paper 38293740 Paper 38274824 Paper 38234830 Paper 38170741 Paper 38154487 Paper 38108398 Paper 38048594 Paper 37908719 Paper 37906513 Paper 37806446 Paper 37799719 Paper 37602700 Paper 37494469 Paper 37480848 Paper 37422574 Paper 37399491 Paper 37379366 Paper 37379285 Paper 37295406 Paper 37214945 Paper 37205431 Paper 37205350 Paper 37196646 Paper 37172287 Paper 37078703 Paper 37009407 Paper 36951958 Paper 36798179 Paper 36736321 Paper 36721042 Paper 36470612 Paper 36453111 Paper 36399701 Paper 36383683 Paper 36379375 Paper 36329015 Paper 36322005 Paper 36287540 Paper 36280104 Paper 36251406 Paper 36210027 Paper 36041227 Paper 35977079 Paper 35852793 Paper 35802462 Paper 35655344 Paper 35613281 Paper 35605246 Paper 35586753 Paper 35561310 Paper 35551658 Paper 35545213 Paper 35484207 Paper 35477992 Paper 35476955 Paper 35430591 Paper 35298559 Paper 35288695 Paper 35286378 Paper 35260532 Paper 35184148 Paper 35151842 Paper 35142567 Paper 35100339 Paper 35061893 Paper 35042232 Paper 34992261 Paper 34969970 Paper 34889392 Paper 34859337 Paper 34778798 Paper 34778797 Paper 34752140 Paper 34653248 Paper 34507354 Trial NCT00398138 Trial NCT00028730 Trial NCT00014469 Patent 9963742 Patent 9919037 Patent 9540448 Patent 9265816 Patent 9074000 Patent 7598221 Patent 7488718 Patent 5824330 Patent 4925919 Patent 4908434 Patent 4908433 Patent 4778879

Abstract

by this Core will continue to facilitate the research and development in the area of hematopoietic stem cell transplantation. The Core activities will accelerate the translational applications in the proposed trials and help improve the outcome in patients undergoing transplantation for a number of malignancies.

View original record on NIH RePORTER →